A carregar...
HCC-derived EGFR mutants are functioning, EGF-dependent, and erlotinib-resistant
BACKGROUND: Epidermal growth factor receptor (EGFR) has emerged as an important therapeutic target. Overexpression of EGFR is frequently observed in hepatocellular carcinoma (HCC) and EGFR activation has been proven to be a potential determinant of primary resistance of HCC cells to sorafenib. In ou...
Na minha lista:
| Publicado no: | Cell Biosci |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7076995/ https://ncbi.nlm.nih.gov/pubmed/32190291 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13578-020-00407-1 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|